Abstract
In mammals, the regulation of the cell fate to either proliferate, differentiate, arrest cell growth, or initiate programmed cell death is the most fundamental mechanism for maintaining normal cell function and tissue homeostasis. Under multiple signaling pathways, Jun and Fos family proteins are known to play important roles as components of an AP-1 (activator protein-1) complex, to regulate the transcription of various genes involved in cell proliferation, differentiation and programmed cell death. ΔFosB, one of the AP-1 subunits encoded by alternatively spliced fosB mRNA, triggers one round of proliferation in quiescent rat embryo cell lines, followed by a different cell fate such as morphological alteration or delayed cell death. As one of the downstream targets of the ΔFosB in rat3Y1 cell line, we identified rat galectin-1 and its novel variant, galectin-1β, and demonstrated that the expression of galectin-1 is required for the proliferative activation of quiescent rat1A cells by ΔFosB, thus indicating that galectin-1 is one of functional targets of ΔFosB. The expression of ΔFosB is highly inducible in the adult brain in response to various insults such as ischemic reperfusion injury, seizure induced by electric stimulation or cocaine administration. On the other hand, galectin- 1 has also been shown to be involved in the regeneration of damaged axons in the peripheral nerve, as well as in neurite outgrowth or synaptic connectivity in the olfactory system during development. We herein propose that ΔFosB together with galectin-1, may therefore mediate neuroprotection and neurogenesis in response to brain damage.
Keywords: alternative splicing, FosB, galectin, redox regulation, cell fate, neuronal fate
Current Drug Targets
Title: Regulation of the Neuronal Fate by ΔFosB and its Downstream Target, Galectin-1
Volume: 6 Issue: 4
Author(s): Tomofumi Miura, Yoshinori Ohnishi, Hideaki Kurushima, Hidenori Horie, Toshihiko Kadoya and Yusaku Nakabeppu
Affiliation:
Keywords: alternative splicing, FosB, galectin, redox regulation, cell fate, neuronal fate
Abstract: In mammals, the regulation of the cell fate to either proliferate, differentiate, arrest cell growth, or initiate programmed cell death is the most fundamental mechanism for maintaining normal cell function and tissue homeostasis. Under multiple signaling pathways, Jun and Fos family proteins are known to play important roles as components of an AP-1 (activator protein-1) complex, to regulate the transcription of various genes involved in cell proliferation, differentiation and programmed cell death. ΔFosB, one of the AP-1 subunits encoded by alternatively spliced fosB mRNA, triggers one round of proliferation in quiescent rat embryo cell lines, followed by a different cell fate such as morphological alteration or delayed cell death. As one of the downstream targets of the ΔFosB in rat3Y1 cell line, we identified rat galectin-1 and its novel variant, galectin-1β, and demonstrated that the expression of galectin-1 is required for the proliferative activation of quiescent rat1A cells by ΔFosB, thus indicating that galectin-1 is one of functional targets of ΔFosB. The expression of ΔFosB is highly inducible in the adult brain in response to various insults such as ischemic reperfusion injury, seizure induced by electric stimulation or cocaine administration. On the other hand, galectin- 1 has also been shown to be involved in the regeneration of damaged axons in the peripheral nerve, as well as in neurite outgrowth or synaptic connectivity in the olfactory system during development. We herein propose that ΔFosB together with galectin-1, may therefore mediate neuroprotection and neurogenesis in response to brain damage.
Export Options
About this article
Cite this article as:
Miura Tomofumi, Ohnishi Yoshinori, Kurushima Hideaki, Horie Hidenori, Kadoya Toshihiko and Nakabeppu Yusaku, Regulation of the Neuronal Fate by ΔFosB and its Downstream Target, Galectin-1, Current Drug Targets 2005; 6 (4) . https://dx.doi.org/10.2174/1389450054021963
DOI https://dx.doi.org/10.2174/1389450054021963 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Iron Overload is Associated with Perihematoma Edema Growth Following Intracerebral Hemorrhage that may Contribute to In-hospital Mortality and Long-term Functional Outcome
Current Neurovascular Research A Dig Deep to Scout the Pharmacological and Clinical Facet of Garlic (<i>Allium sativum</i>)
Current Traditional Medicine In vivo Optical Molecular Imaging of Cardiovascular Diseases: Long Road Ahead
Current Molecular Imaging (Discontinued) Small Molecule Antagonists of Integrin Receptors
Current Medicinal Chemistry High Density Lipoprotein Administration: A New Therapeutic Modality for the Treatment of Cardiovascular Diseases
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The Role of 18 kDa Mitochondrial Translocator Protein (TSPO) in Programmed Cell Death, and Effects of Steroids on TSPO Expression
Current Molecular Medicine White Matter Neuroprotection in Preterm Infants
Current Pediatric Reviews Mitochondrion-Specific Antioxidants as Drug Treatments for Alzheimer Disease
CNS & Neurological Disorders - Drug Targets CCL2-CCR2 Signaling in Disease Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets The Coronary Collateral Circulation in Man
Current Cardiology Reviews Chinese Medicinal Herbs as Source of Antioxidant Compounds – Where Tradition Meets the Future
Current Medicinal Chemistry Hsp20 Protects Neuroblastoma Cells from Ischemia/Reperfusion Injury by Inhibition of Apoptosis via a Mechanism that Involves the Mitochondrial Pathways
Current Neurovascular Research Genetics in Anti-Platelet Treatment
Current Pharmaceutical Design A Lipid Anchor Improves the Protective Effect of Ectoine in Inflammation
Current Medicinal Chemistry Pericyte: Potential Target for Hemorrhagic Stroke Prevention and Treatment
Current Drug Delivery Cannabinoid CB2 Receptors in Health and Disease
Current Medicinal Chemistry Heme Oxygenase Overexpression Attenuates Glucose-Mediated Oxidative Stress in Quiescent Cell Phase: Linking Heme to Hyperglycemia Complications
Current Neurovascular Research Blocking Leukocyte Rolling: Does it have a Role in Disease Prevention?
Vascular Disease Prevention (Discontinued) Cardioprotection with opioids - Trusted old friends -Clinical Science -
Current Pharmaceutical Design The Effect of Lipoic Acid on Macro and Trace Metal Levels in Living Tissues Exposed to Oxidative Stress
Anti-Cancer Agents in Medicinal Chemistry